Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 3/20 | 0.49 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | BID | P55957 | 3/20 | 0.38 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.38 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.38 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.38 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.38 |
| ▸ | PPARG | P37231 | 1/20 | 0.38 |
| ▸ | PPARA | Q07869 | 1/20 | 0.38 |
| ▸ | EP300 | Q09472 | 1/20 | 0.38 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL793459 | 1.00 | TYR (0.49) | TYRTP53CYP3A4MEN1ALOX5 | |
| Formaldehyde SCHEMBL11797157 | 0.96 | TYR (0.46) | TYRTP53CYP3A4MEN1ALOX5 | |
| Formaldehyde SCHEMBL10958112 | 0.96 | TYR (0.46) | TYRTP53CYP3A4MEN1ALOX5 | |
| SCHEMBL6037106 | 0.88 | TYR (0.49) | TYRTP53CYP3A4MEN1ALOX5 | |
| SCHEMBL1331807 | 0.85 | AKT1 (0.36) | TYRTP53CYP3A4MEN1ALOX5 | |
| SCHEMBL251633 | 0.81 | HTR2A (0.37) | TYRTP53CYP3A4MEN1ALOX5 | |
| SCHEMBL250560 | 0.81 | HTR2A (0.37) | TYRTP53CYP3A4MEN1ALOX5 | |
| SCHEMBL1525666 | 0.81 | HTR2A (0.37) | TYRTP53CYP3A4MEN1ALOX5 | |
| SCHEMBL3262720 | 0.81 | HTR2A (0.37) | TYRTP53CYP3A4MEN1ALOX5 | |
| SCHEMBL7934677 | 0.81 | HTR2A (0.37) | TYRTP53CYP3A4MEN1ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114479734-A | Insulating adhesive film, preparation method and application thereof | 深圳先进电子材料国际创新研究院 | 2022-05-13 | — | — | CN | claimed |
| EP-0287327-B1 | Compounds for determining cations | MILES INC (US) | 1994-07-27 | — | — | EP | claimed |
| EP-0352264-B1 | USE OF POLYOXYETHYLENE ETHERS TO IMPROVE THE PERFORMANCE OF IMMUNOASSAYS EMPLOYING PEROXIDASE CONJUGATES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-04-01 | — | — | EP | claimed |
| US-5077199-A | Comprising glucose oxidase free from catalase and nonionic surfactant stabilizer | A. MENARINI S.A.S. (IT) | 1991-12-31 | — | — | US | claimed |
| EP-0352264-A4 | USE OF POLYOXYETHYLENE ETHERS TO IMPROVE THE PERFORMANCE OF IMMUNOASSAYS EMPLOYING PEROXIDASE CONJUGATES. | DU PONT (US) | 1990-02-20 | — | — | EP | claimed |
| EP-0352264-A1 | USE OF POLYOXYETHYLENE ETHERS TO IMPROVE THE PERFORMANCE OF IMMUNOASSAYS EMPLOYING PEROXIDASE CONJUGATES. | DU PONT (US) | 1990-01-31 | — | — | EP | claimed |
| US-4810630-A | REDUCED INTERFERENCE BY BLOOD | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-03-07 | — | — | US | claimed |
| WO-1988007683-A1 | USE OF POLYOXYETHYLENE ETHERS TO IMPROVE THE PERFORMANCE OF IMMUNOASSAYS EMPLOYING PEROXIDASE CONJUGATES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-10-06 | — | — | WO | claimed |
| EP-0169055-A2 | Polymeric single layer analytical element | TECHNICON INSTRUMENTS CORPORATION(a Delaware corporation) (US) | 1986-01-22 | — | — | EP | claimed |
| CN-114479734-A | Insulating adhesive film, preparation method and application thereof | 深圳先进电子材料国际创新研究院 | 2022-05-13 | — | — | CN | disclosed |
| EP-3732188-A1 | METHOD FOR PURIFYING ANTIBODIES FROM RAW MILK | Laboratoire Français du Fractionnement et des Biotechnologies (FR) | 2020-11-04 | — | — | EP | disclosed |
| EP-1071457-B1 | POLYMER PARTICLE VACCINE DELIVERY SYSTEM | ASTRAZENECA AB (SE) | 2012-02-15 | — | — | EP | disclosed |
| US-20090176736-A1 | PHARMACEUTICAL COMPOSITION FOR CONFORMATIONAL DISEASES | NATIONAL UNIVERSITY CORPORATION TOHOKU UNIVERSITY (JP) | 2009-07-09 | — | — | US | disclosed |
| EP-2017289-A1 | PHARMACEUTICAL COMPOSITION FOR CONFORMATIONAL DISEASE | Itoham Foods Inc. (JP) | 2009-01-21 | — | — | EP | disclosed |
| EP-0352264-A1 | USE OF POLYOXYETHYLENE ETHERS TO IMPROVE THE PERFORMANCE OF IMMUNOASSAYS EMPLOYING PEROXIDASE CONJUGATES. | DU PONT (US) | 1990-01-31 | — | — | EP | disclosed |
| EP-0042766-B2 | HIGHLY ANISOTROPIC MEMBRANES AND PROCESS FOR MAKING SAME | PUROPORE, INC. (US) | 1989-11-02 | — | — | EP | disclosed |
| US-4810630-A | REDUCED INTERFERENCE BY BLOOD | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-03-07 | — | — | US | disclosed |
| WO-1988007683-A1 | USE OF POLYOXYETHYLENE ETHERS TO IMPROVE THE PERFORMANCE OF IMMUNOASSAYS EMPLOYING PEROXIDASE CONJUGATES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-10-06 | — | — | WO | disclosed |
| US-4333972-A | POLYMERS, METHYL FORMATE, ISOPROPANOL | PUROPORE, INC. (US) | 1982-06-08 | — | — | US | disclosed |
| EP-0042766-A2 | Highly anisotropic membranes and process for making same | PUROPORE, INC. (US) | 1981-12-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090176736-A1 | PHARMACEUTICAL COMPOSITION FOR CONFORMATIONAL DISEASES | PRNP, APP, PSEN1 | TYR 1484/4885TP53 1420/4885CYP3A4 1838/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.